Royalty Pharma PLC (RPRX) — DEFA14A Filings

All DEFA14A filings from Royalty Pharma PLC. Browse 3 DEFA14A reports with AI-powered summaries and risk analysis.

DEFA14A Filings (3)

Royalty Pharma Files Preliminary Proxy for Deal — Mar 5, 2025 Risk: medium
Royalty Pharma plc filed a DEFA14A on March 5, 2025, related to preliminary proxy materials for a proposed transaction. This filing indicates that the company i
Royalty Pharma Preps Proxy for Key Transaction — Jan 17, 2025 Risk: low
Royalty Pharma plc filed a DEFA14A, indicating it is soliciting materials prior to furnishing a definitive proxy statement for a proposed transaction. The filin
Royalty Pharma plc Files Proxy Statement for Proposed Transaction — Jan 16, 2025 Risk: low
Royalty Pharma plc is filing a DEFA14A, indicating it is soliciting materials prior to furnishing a definitive proxy statement for a proposed transaction. The f

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX